Author:
Somesh Baggavalli P,Verma Mahesh Kumar,Sadasivuni Manoj Kumar,Mammen-Oommen Anup,Biswas Sanghamitra,Shilpa Pavagada C,Reddy Ashok Kumar,Yateesh Aggunda N,Pallavi Puttrevana M,Nethra Siddaraju,Smitha Rachapalli,Neelima Korrapati,Narayanan Usha,Jagannath Madanahalli R
Abstract
Abstract
Background
In the progression towards diabetes, glucolipotoxicity is one of the main causes of pancreatic beta cell pathology. The aim of this study was to examine the in vitro effects of chronic glucolipotoxic conditions on cellular responses in pancreatic islets, including glucose and fat metabolism, Calcium mobilization, insulin secretion and insulin content.
Results
Exposure of islets to chronic glucolipotoxic conditions decreased glucose stimulated insulin secretion in vitro. Reduced protein levels of Glut2/slc2a2, and decreased glucokinase and pyruvate carboxylase mRNA levels indicated a significant lowering in glucose sensing. Concomitantly, both fatty acid uptake and triglyceride accumulation increased significantly while fatty acid oxidation decreased. This general suppression in glucose metabolism correlated well with a decrease in mitochondrial number and activity, reduction in cellular ATP content and dampening of the TCA cycle. Further, we also observed a decrease in IP3 levels and lower Calcium mobilization in response to glucose. Importantly, chronic glucolipotoxic conditions in vitro decreased insulin gene expression, insulin content, insulin granule docking (to the plasma membrane) and insulin secretion.
Conclusions
Our results present an integrated view of the effects of chronic glucolipotoxic conditions on known and novel signaling events, in vitro, that results in reduced glucose responsiveness and insulin secretion.
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Prentki M, Nolan CJ: Islet beta cell failure in type 2 diabetes. J Clin Invest. 2006, 116: 1802-1812. 10.1172/JCI29103.
2. Defronzo RA: Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009, 58: 773-795. 10.2337/db09-9028.
3. Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontés G: Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta. 1801, 2010: 289-298.
4. Poitout V, Robertson RP: Secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity. Endocrinology. 2002, 143: 339-342. 10.1210/en.143.2.339.
5. El-Assaad W, Buteau J, Peyot ML, Nolan C, Roduit R, Hardy S, Joly E, Dbaibo G, Rosenberg L, Prentki M: Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinol. 2003, 144: 4154-4163. 10.1210/en.2003-0410.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献